2015 Kentucky Revised Statutes
CHAPTER 311 - PHYSICIANS, OSTEOPATHS, PODIATRISTS, AND RELATED MEDICAL PRACTITIONERS
311.964 Health care facility not to restrict use of laetrile -- Exception.
Download as PDF
311.964 Health care facility not to restrict use of laetrile -- Exception.
(1)
(2)
When amygdalin (laetrile) is prescribed or administered by a physician holding a
regular license for the practice of medicine in the State of Kentucky and the patient
has signed a written informed request form, except as provided in subsection (2) of
this section, a hospital or other health care facility shall not restrict or forbid the use
of amygdalin (laetrile) in the treatment of any malignancy, disease, illness or
physical condition.
If the federal government states that it will withdraw all federal funds from a health
care facility for allowing amygdalin (laetrile) to be used within the facility, and if
providing or allowing its use within the facility would jeopardize the receipt of
federal funds for reimbursement for medicine or Medicaid for all persons within the
facility, or any construction funds provided by the federal government under the
Hill-Burton Hospital Construction Program or under Title XVI of the Public Health
Services Act, the hospital or other health care facility may, notwithstanding the
provisions of subsection (1) of this section, prohibit the use of amygdalin (laetrile)
within its facility.
Effective: July 15, 1980
History: Created 1980 Ky. Acts ch. 354, sec. 11, effective July 15, 1980.
Disclaimer: These codes may not be the most recent version. Kentucky may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.